Cargando…
CLINICAL EFFECTIVENESS AND ADVERSE EVENTS OF ADJUNCTIVE REMDESIVIR ADMINISTRATION VS STANDARD OF CARE IN ADULTS WITH SEVERE AND CRITICAL COVID-19
INTRO: The unavailability of specific treatment for COVID-19 prompted the empirical use of remdesivir, a viral RNA polymerase inhibitor. Since evidences present conflicting results, this study aims to determine the clinical effectiveness and adverse events of adjunctive remdesivir administration vs...
Autores principales: | Viray, D.D., Cajulao, T.P., Demot, B., Bartolo, S., Feliciano, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186882/ http://dx.doi.org/10.1016/j.ijid.2023.04.352 |
Ejemplares similares
-
WCN23-0389 ASSOCIATED FACTORS TO CLINICAL OUTCOMES OF COVID-19 AMONG HOSPITALIZED PATIENTS UNDERGOING MAINTENANCE DIALYSIS
por: MEDRIANO, R., et al.
Publicado: (2023) -
Remdesivir vs tocilizumab in COVID-19: adverse event profiles
Publicado: (2021) -
Outbreak of Ralstonia bacteraemia among chronic kidney disease patients in a haemodialysis unit in the Philippines
por: Aranas, Denmarc R, et al.
Publicado: (2022) -
Effect of Remdesivir Administration on Occurrence of Major Adverse Cardiac Events in Critically Ill COVID-19 Pneumonia: A Retrospective Observational Study
por: Panda, Rajesh, et al.
Publicado: (2022) -
Cardiac Adverse Events With Remdesivir in COVID-19 Infection
por: Gupta, Anupam K, et al.
Publicado: (2020)